Drug Type Biosimilar, Hormone |
Synonyms AFOLIA, Bemfola, Bemfola Pen + [8] |
Target |
Mechanism FSHR agonists(Follicle-stimulating hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (26 Mar 2014), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anovulation | IS | 26 Mar 2014 | |
Anovulation | NO | 26 Mar 2014 | |
Anovulation | LI | 26 Mar 2014 | |
Anovulation | EU | 26 Mar 2014 | |
Hypogonadism | IS | 26 Mar 2014 | |
Hypogonadism | LI | 26 Mar 2014 | |
Hypogonadism | EU | 26 Mar 2014 | |
Hypogonadism | NO | 26 Mar 2014 | |
Polycystic Ovary Syndrome | EU | 26 Mar 2014 | |
Polycystic Ovary Syndrome | NO | 26 Mar 2014 | |
Polycystic Ovary Syndrome | IS | 26 Mar 2014 | |
Polycystic Ovary Syndrome | LI | 26 Mar 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infertility | Phase 1 | DK | 01 Jun 2010 | |
Infertility | Phase 1 | CH | 01 Jun 2010 | |
Infertility | Phase 1 | DE | 01 Jun 2010 | |
Infertility | Phase 1 | GB | 01 Jun 2010 | |
Infertility | Phase 1 | AT | 01 Jun 2010 | |
Infertility | Discovery | ES | 01 Jun 2010 |
Phase 3 | 1,100 | (AFOLIA) | jgzsuvqssc(fgpozbtgeb): Risk Difference (RD) = 3.7 (95% CI, -1.3 to 8.7) View more | - | 18 Oct 2017 | ||
(Gonal-f® RFF) | |||||||
Phase 3 | 460 | (AFOLIA-150 (Follitropin Alfa)) | uhyyplbbnc(heiwgssgqi) = gizrodlmkk wyvwlunfyi (dpgtrvetzx, mcwdvpyyry - nvqcwmsxvl) View more | - | 15 Apr 2016 | ||
(Gonal-f® (Follitropin Alfa)) | uhyyplbbnc(heiwgssgqi) = hrbfroseke wyvwlunfyi (dpgtrvetzx, ikrrotuica - rnizghllor) View more |